Mohammad Abufaraj

6.0k citations

172 papers · 3.4k indexed · 2 hit papers · h-index 32

Impact in

Urology top 0.5%
- Urological Disorders and Treatments
Surgery top 2%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies

Papers in

Urology 40
- Urological Disorders and Treatments 32
- Urinary Bladder and Prostate Research 9
Surgery 109
- Bladder and Urothelial Cancer Treatments 99
- Urinary and Genital Oncology Studies 75

Co-authors: Shahrokh F. Shariat Shoji Kimura Beat Foerster Pierre I. Karakiewicz David D‘Andrea Marco Moschini Francesco Soria Alberto Briganti
Journals: Urologic Oncology Seminars and Original Investigations (28 papers)World Journal of Urology (19 papers)Clinical Genitourinary Cancer (16 papers)Current Opinion in Urology (16 papers)European Urology Focus (8 papers)
Partner nations: Austria Jordan United States

In The Last Decade

Mohammad Abufaraj

168 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Magnetic Resonance Imaging in Prostate Cancer Screening 2024 · 34 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2024 JAMA Oncology
2021 American Journal of Obstetrics and Gynecology

Peers

Countries citing papers authored by Mohammad Abufaraj

Since Specialization

Citations

This map shows the geographic impact of Mohammad Abufaraj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Abufaraj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Abufaraj more than expected).

Fields of papers citing papers by Mohammad Abufaraj

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Abufaraj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Abufaraj. The network helps show where Mohammad Abufaraj may publish in the future.

Co-authors

The 25 scholars most cited alongside Mohammad Abufaraj, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mohammad Abufaraj Line = papers co-authored together Mohammad Abufaraj links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Exploring Factors Influencing Medical Trainees’ Specialty Choice: Insights from a Nationwide Cross-Sectional Survey in Jordan Teaching and Learning in Medicine ·Osama Aldahamsheh, Sereen Halayqeh, May Alfayyadh, Zina Smadi, Sara Abu Halimeh, Mary Almadani, Wathiq Shatnawi, Sarah Ellouzy, Mohammad Abufaraj	2024	1
2	Adjuvant intravesical therapy in intermediate‐risk non‐muscle‐invasive bladder cancer British Journal of Urology ·Ekaterina Laukhtina, Paolo Gontero, Marko Babjuk, Marco Moschini, Jeremy Yuen‐Chun Teoh, Morgan Rouprêt, Quoc‐Dien Trinh, Piotr Chłosta, Péter Nyírády, Mohammad Abufaraj, Francesco Soria, Jakob Klemm, Kensuke Bekku, Akihiro Matsukawa, Shahrokh F. Shariat	2024	2
3	Upper Tract Urothelial Carcinoma: A Narrative Review of Current Surveillance Strategies for Non-Metastatic Disease Cancers ·Jakob Klemm, Kensuke Bekku, Mohammad Abufaraj, Ekaterina Laukhtina, Akihiro Matsukawa, Mehdi Kardoust Parizi, Pierre I. Karakiewicz, Shahrokh F. Shariat	2023	2
4	The prevalence of overactive bladder and its impact on the quality of life: A cross-sectional study Arab Journal of Urology ·Shrouq Qudah, Mohammad Abufaraj, Randa Farah, Abdulrahman Almazeedi, Ali Ababneh, Mazen Alnabulsi, Ayman Qatawneh, Dana Hyassat, Kamel Ajlouni	2023	5
5	The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC) Clinical Genitourinary Cancer ·Beat Foerster, Mohammad Abufaraj, Andrea Mari, Thomas Seisen, Marco Bandini, D.G. Schweitzer, Anna Czech, Marco Moschini, David D‘Andrea, Marco Bianchi, Kees Hendricksen, Morgan Rouprêt, Alberto Briganti, Bas W.G. van Rhijn, Piotr Chłosta, Pierre Colin, Hubert John, Shahrokh F. Shariat	2020	11
6	Diagnostic challenges and treatment strategies in the management of upper-tract urothelial carcinoma SHILAP Revista de lepidopterología ·Victor M. Schuettfort, Benjamin Pradère, Fahad Quhal, Hadi Mostafaei, Ekaterina Laukhtina, Keiichiro Mori, Reza Sari Motlagh, Michael Rink, David D‘Andrea, Pierre I. Karakiewicz, Shahrokh F. Shariat, Mohammad Abufaraj	2020	2
7	Viewpoint: Jordan’s public and surveillance health policies: During and after COVID-19 Jordan Journal of Pharmaceutical Sciences ·Raeda Al Qutob, Musa T. Ajlouni, Mohammad Abufaraj, R D Immanuel Azaad Moonesar	2020	3
8	The prognostic value of the urokinase-plasminogen activator system (uPA) in bladder cancer patients treated with radical cystectomy (RC) Urologic Oncology Seminars and Original Investigations ·Florian Janisch, David D‘Andrea, Takehiro Iwata, Shoji Kimura, Mohammad Abufaraj, Dmitry Enikeev, Petr Glybochko, Pierre I. Karakiewicz, Péter Nyírády, Harun Fajković, Andrea Haitel, Veronika Seebacher, Michael Rink, Shahrokh F. Shariat	2020	7
9	The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy Urologic Oncology Seminars and Original Investigations ·Mohammad Abufaraj, Shoji Kimura, Andrea Haitel, Takehiro Iwata, Ula Isleem, David D‘Andrea, Francesco Soria, Keiichiro Mori, Michael Rink, Karim Bensalah, Morgan Rouprêt, Vitaly Margulis, Alberto Briganti, Pierre I. Karakiewicz, Shahrokh F. Shariat	2020	2
10	Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis Urologic Oncology Seminars and Original Investigations ·Mehdi Kardoust Parizi, Mohammad Abufaraj, Harun Fajković, Shoji Kimura, Takehiro Iwata, David D‘Andrea, Pierre I. Karakiewicz, Shahrokh F. Shariat	2019	25
11	Current Disease Management of Primary Urethral Carcinoma European Urology Focus ·Florian Janisch, Mohammad Abufaraj, Harun Fajković, Shoji Kimura, Takehiro Iwata, Péter Nyírády, Michael Rink, Shahrokh F. Shariat	2019	27
12	A systematic review and meta-analysis of lymphovascular invasion in patients treated with radical cystectomy for bladder cancer Urologic Oncology Seminars and Original Investigations ·Andrea Mari, Shoji Kimura, Beat Foerster, Mohammad Abufaraj, David D‘Andrea, Kilian M. Gust, Shahrokh F. Shariat	2018	39
13	Prognostic value of modified Glasgow Prognostic Score in non–muscle-invasive bladder cancer Urologic Oncology Seminars and Original Investigations ·Shoji Kimura, D. D Andrea, Francesco Soria, Beat Foerster, Mohammad Abufaraj, Mihai Dorin Vartolomei, Takehiro Iwata, Pierre I. Karakiewicz, Michael Rink, Kilian M. Gust, Shin Egawa, Shahrokh F. Shariat	2018	19
14	Role of serum cholinesterase in patients treated with salvage radical prostatectomy Urologic Oncology Seminars and Original Investigations ·Mihai Dorin Vartolomei, David D‘Andrea, Daher Chade, Francesco Soria, Shoji Kimura, Beat Foerster, Mohammad Abufaraj, Romain Mathiéu, Marco Moschini, Morgan Rouprêt, Alberto Briganti, Pierre I. Karakiewicz, Shahrokh F. Shariat	2018	11
15	The impact of moderate wine consumption on the risk of developing prostate cancer Clinical Epidemiology ·Mihai Dorin Vartolomei, Shoji Kimura, Matteo Ferro, Beat Foerster, Mohammad Abufaraj, Alberto Briganti, Pierre I. Karakiewicz, Shahrokh F. Shariat	2018	19
16	A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens British Journal of Urology ·Andrea Mari, Shoji Kimura, Beat Foerster, Mohammad Abufaraj, David D‘Andrea, Melanie R. Hassler, Andrea Minervini, Morgan Rouprêt, Marko Babjuk, Shahrokh F. Shariat	2018	46
17	Prognostic Value of Serum Cholinesterase in Non–muscle-invasive Bladder Cancer Clinical Genitourinary Cancer ·Shoji Kimura, Francesco Soria, David D‘Andrea, Beat Foerster, Mohammad Abufaraj, Mihai Dorin Vartolomei, Pierre I. Karakiewicz, Romain Mathiéu, Marco Moschini, Michael Rink, Shin Egawa, Shahrokh F. Shariat, Kilian M. Gust	2018	17
18	Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy Urologic Oncology Seminars and Original Investigations ·David D‘Andrea, Francesco Soria, Mohammad Abufaraj, Kilian M. Gust, Beat Foerster, Mihai Dorin Vartolomei, Shoji Kimura, Andrea Mari, Alberto Briganti, Mesut Remzi, C. Seitz, Romain Mathiéu, Pierre I. Karakiewicz, Shahrokh F. Shariat	2018	12
19	Comparative Effectiveness in Perioperative Outcomes of Robotic versus Open Radical Cystectomy: Results from a Multicenter Contemporary Retrospective Cohort Study European Urology Focus ·Francesco Soria, Marco Moschini, David D‘Andrea, Mohammad Abufaraj, Beat Foerster, Romain Mathiéu, K. Gust, Paolo Gontero, Giuseppe Simone, Anoop Meraney, Suprita Krishna, Badrinath R. Konety, Morgan Rouprêt, Matthew Perry, Edward Rowe, Guillaume Ploussard, Stephen A. Boorjian, Peter Wiklund, Prasanna Sooriakumaran, Shahrokh F. Shariat	2018	28
20	Predictive and Prognostic Value of Preoperative Thrombocytosis in Upper Tract Urothelial Carcinoma Clinical Genitourinary Cancer ·Beat Foerster, Marco Moschini, Mohammad Abufaraj, Francesco Soria, Kilian M. Gust, Morgan Rouprêt, Pierre I. Karakiewicz, Alberto Briganti, Michael Rink, Luis A. Kluth, Romain Mathiéu, Vitaly Margulis, Yair Lotan, Atiqullah Aziz, Hubert John, Shahrokh F. Shariat	2017	11

About Mohammad Abufaraj

Mohammad Abufaraj is a scholar working on Urology, Surgery, Pulmonary and Respiratory Medicine, Oncology and Rheumatology, having authored 172 papers that have together received 3.4k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (99 papers), Urinary and Genital Oncology Studies (75 papers), Prostate Cancer Diagnosis and Treatment (33 papers), Urological Disorders and Treatments (32 papers), Prostate Cancer Treatment and Research (30 papers), Inflammatory Biomarkers in Disease Prognosis (14 papers), Renal cell carcinoma treatment (12 papers) and Urinary Bladder and Prostate Research (9 papers). The work is most often cited by research in Urology (571 citations), Surgery (1.8k citations), Pulmonary and Respiratory Medicine (1.0k citations), Oncology (760 citations) and Rheumatology (249 citations). Mohammad Abufaraj has collaborated with scholars based in Austria, Jordan and United States. Frequent co-authors include Shahrokh F. Shariat, Shoji Kimura, Beat Foerster, Pierre I. Karakiewicz, David D‘Andrea, Marco Moschini, Francesco Soria, Alberto Briganti, Lin Yang and Andrea Mari. Their work appears in journals such as Urologic Oncology Seminars and Original Investigations, World Journal of Urology, Clinical Genitourinary Cancer, Current Opinion in Urology and European Urology Focus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact